Ivax Glucophage XR Launch Halted By Purepac Exclusivity Suit
Executive Summary
Purepac's lawsuit over FDA's 180-day exclusivity determination on generic metformin extended-release challenges the agency's interpretation of first-to-file rights for amended ANDAs